BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Diawara I, Zerouali K, Katfy K, Zaki B, Belabbes H, Najib J, Elmdaghri N. Invasive pneumococcal disease among children younger than 5 years of age before and after introduction of pneumococcal conjugate vaccine in Casablanca, Morocco. Int J Infect Dis 2015;40:95-101. [PMID: 26434380 DOI: 10.1016/j.ijid.2015.09.019] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Ngocho JS, Magoma B, Olomi GA, Mahande MJ, Msuya SE, de Jonge MI, Mmbaga BT. Effectiveness of pneumococcal conjugate vaccines against invasive pneumococcal disease among children under five years of age in Africa: A systematic review. PLoS One 2019;14:e0212295. [PMID: 30779801 DOI: 10.1371/journal.pone.0212295] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
2 Tin Tin Htar M, van Den Biggelaar AHJ, Sings H, Ferreira G, Moffatt M, Hall-Murray C, Verstraeten T, Gessner BD, Schmitt HJ, Jodar L. The impact of routine childhood immunization with higher-valent pneumococcal conjugate vaccines on antimicrobial-resistant pneumococcal diseases and carriage: a systematic literature review. Expert Rev Vaccines 2019;18:1069-89. [PMID: 31585049 DOI: 10.1080/14760584.2019.1676155] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
3 Néhémie N, Zerouali K, Diawara I, Katfy K, Maaloum F, Kabura S, Zaki B, Farid C, Belabbes H, Elmdaghri N. Surgical wound infection caused by a multi drug resistant Streptococcus pneumoniae Serotype 19A after a total coloproctectomy with ileostomy. Pan Afr Med J 2020;35:97. [PMID: 32636995 DOI: 10.11604/pamj.2020.35.97.19128] [Reference Citation Analysis]
4 Diawara I, Barguigua A, Katfy K, Nayme K, Belabbes H, Timinouni M, Zerouali K, Elmdaghri N. Molecular characterization of penicillin non-susceptible Streptococcus pneumoniae isolated before and after pneumococcal conjugate vaccine implementation in Casablanca, Morocco. Ann Clin Microbiol Antimicrob 2017;16:23. [PMID: 28376809 DOI: 10.1186/s12941-017-0200-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
5 Pugh SJ, Fletcher MA, Charos A, Imekraz L, Wasserman M, Farkouh R. Cost-Effectiveness of the Pneumococcal Conjugate Vaccine (10- or 13-Valent) Versus No Vaccination for a National Immunization Program in Tunisia or Algeria. Infect Dis Ther 2019;8:63-74. [PMID: 30539417 DOI: 10.1007/s40121-018-0226-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
6 Nzoyikorera N, Diawara I, Fresia P, Maaloum F, Katfy K, Nayme K, Maaloum M, Cornick J, Chaguza C, Timinouni M, Belabess H, Zerouali K, Elmdaghri N. Whole genomic comparative analysis of Streptococcus pneumoniae serotype 1 isolates causing invasive and non-invasive infections among children under 5 years in Casablanca, Morocco. BMC Genomics 2021;22:39. [PMID: 33413118 DOI: 10.1186/s12864-020-07316-0] [Reference Citation Analysis]
7 Diawara I, Zerouali K, Katfy K, Barguigua A, Belabbes H, Timinouni M, Elmdaghri N. Phenotypic and genotypic characterization of Streptococcus pneumoniae resistant to macrolide in Casablanca, Morocco. Infect Genet Evol 2016;40:200-4. [PMID: 26961592 DOI: 10.1016/j.meegid.2016.03.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
8 Nahm MH, Brissac T, Kilian M, Vlach J, Orihuela CJ, Saad JS, Ganaie F. Pneumococci Can Become Virulent by Acquiring a New Capsule From Oral Streptococci. J Infect Dis 2020;222:372-80. [PMID: 31605125 DOI: 10.1093/infdis/jiz456] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Wasserman MD, Sings HL, Wilson MR, Postma MJ, Breton MC, McDade C, Farkouh RA. Re-Analysis of Modeling a Switch from a 13-Valent to 10-Valent Pneumococcal Conjugate Vaccine in Canada: Leveraging Real-World Experience from Belgium. Infect Dis Ther 2019;8:1-3. [PMID: 30460606 DOI: 10.1007/s40121-018-0222-1] [Reference Citation Analysis]
10 Izurieta P, Breuer T. Interpretation of the switch in a childhood pneumococcal vaccination programme from PCV13 to PCV10 in Belgium. The Lancet Infectious Diseases 2018;18:831-2. [DOI: 10.1016/s1473-3099(18)30410-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
11 Dilagui I, Moussair F, Loqman S, Diawara I, Zerouali K, Belabbes H, Zouhair S, Bourouss M, Bouskraoui M, Soraa N. Streptococcus pneumoniae carriage among febrile children at the time of PCV-10 immunization in pediatric emergencies at Mohammed VI University Hospital Centre in Marrakesh (Morocco). Archives de Pédiatrie 2019;26:453-8. [DOI: 10.1016/j.arcped.2019.08.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
12 Haddad-Boubaker S, Lakhal M, Fathallah C, Mhimdi S, Bouafsoun A, Kechrid A, Smaoui H. Epidemiological study of bacterial meningitis in Tunisian children, beyond neonatal age, using molecular methods: 2014-2017. Afr Health Sci 2020;20:1124-32. [PMID: 33402957 DOI: 10.4314/ahs.v20i3.14] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Wouters I, Desmet S, Van Heirstraeten L, Blaizot S, Verhaegen J, Van Damme P, Malhotra-Kumar S, Theeten H; NPcarriage Study Group. Follow-up of serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae in child carriage after a PCV13-to-PCV10 vaccine switch in Belgium. Vaccine 2019;37:1080-6. [PMID: 30665775 DOI: 10.1016/j.vaccine.2018.12.068] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
14 Cohen R, Cohen JF, Chalumeau M, Levy C. Impact of pneumococcal conjugate vaccines for children in high- and non–high-income countries. Expert Review of Vaccines 2017;16:625-40. [DOI: 10.1080/14760584.2017.1320221] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 7.2] [Reference Citation Analysis]
15 Nieto Guevara J, Borys D, DeAntonio R, Guzman-Holst A, Hoet B. Interchangeability between pneumococcal conjugate vaccines for pediatric use: a systematic literature review. Expert Rev Vaccines 2020;19:1011-22. [PMID: 31751159 DOI: 10.1080/14760584.2019.1688148] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 de Los Santos AM, Rodríguez-Weber MA, Sánchez-Márquez P, Traskine M, Carreño-Manjarrez R, Cervantes-Apolinar MY, Strezova A, Ruiz-Guiñazú J, Ortega-Barria E, Borys D. Can two different pneumococcal conjugate vaccines be used to complete the infant vaccination series? A randomized trial exploring interchangeability of the 13-valent pneumococcal conjugate vaccine and the pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine. Expert Rev Vaccines 2020;19:995-1010. [PMID: 33297773 DOI: 10.1080/14760584.2020.1843431] [Reference Citation Analysis]
17 Diawara I, Zerouali K, Elmdaghri N, Abid A. A case report of parapneumonic pleural effusion caused by Streptococcus pneumoniae serotype 19A in a child immunized with 13-valent conjugate pneumococcal vaccine. BMC Pediatr 2017;17:114. [PMID: 28449653 DOI: 10.1186/s12887-017-0872-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
18 Suwantika AA, Zakiyah N, Kusuma ASW, Abdulah R, Postma MJ. Impact of Switch Options on the Economics of Pneumococcal Conjugate Vaccine (PCV) Introduction in Indonesia. Vaccines (Basel) 2020;8:E233. [PMID: 32443523 DOI: 10.3390/vaccines8020233] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
19 Mungall BA, Hoet B, Nieto Guevara J, Soumahoro L. A systematic review of invasive pneumococcal disease vaccine failures and breakthrough with higher-valency pneumococcal conjugate vaccines in children. Expert Rev Vaccines 2021. [PMID: 34882050 DOI: 10.1080/14760584.2022.2012455] [Reference Citation Analysis]
20 Wang LM, Cravo Oliveira Hashiguchi T, Cecchini M. Impact of vaccination on carriage of and infection by antibiotic-resistant bacteria: a systematic review and meta-analysis. Clin Exp Vaccine Res 2021;10:81-92. [PMID: 34222121 DOI: 10.7774/cevr.2021.10.2.81] [Reference Citation Analysis]
21 Ktari S, Jmal I, Mroua M, Maalej S, Ben Ayed NE, Mnif B, Rhimi F, Hammami A. Serotype distribution and antibiotic susceptibility of Streptococcus pneumoniae strains in the south of Tunisia: A five-year study (2012–2016) of pediatric and adult populations. International Journal of Infectious Diseases 2017;65:110-5. [DOI: 10.1016/j.ijid.2017.10.015] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
22 Chikhaoui A, Nzoyikorera N, El Mouadden M, Al Zemmouri M, Zerouali K, Moschovi M. A Rare Case of Pneumococcal Appendicitis in a Child. Case Reports in Pediatrics 2022;2022:1-3. [DOI: 10.1155/2022/9262149] [Reference Citation Analysis]
23 Fletcher MA, Haridy H. Decline in childhood respiratory-related mortality after the introduction of the pneumococcal conjugate vaccine in Morocco. J Infect Public Health 2021;14:387-8. [PMID: 33676195 DOI: 10.1016/j.jiph.2020.12.032] [Reference Citation Analysis]
24 Mechita NB, Obtel M, Elmarnissi A, Lahlou L, Lyaghfouri A, Cherkaoui I, Mrabet M, Razine R, Abouqal R. Response to the letter to the editor. J Infect Public Health 2021;14:385-6. [PMID: 33667894 DOI: 10.1016/j.jiph.2021.01.001] [Reference Citation Analysis]